Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections
- PMID: 33620654
- DOI: 10.1007/978-3-030-65481-8_9
Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections
Abstract
Human infections with the food-borne pathogen Campylobacter jejuni are progressively increasing worldwide and constitute a significant socioeconomic burden to mankind. Intestinal campylobacteriosis in humans is characterized by bloody diarrhea, fever, abdominal pain, and severe malaise. Some individuals develop chronic post-infectious sequelae including neurological and autoimmune diseases such as reactive arthritis and Guillain-Barré syndrome. Studies unraveling the molecular mechanisms underlying campylobacteriosis and post-infectious sequelae have been hampered by the scarcity of appropriate experimental in vivo models. Particularly, conventional laboratory mice are protected from C. jejuni infection due to the physiological colonization resistance exerted by the murine gut microbiota composition. Additionally, as compared to humans, mice are up to 10,000 times more resistant to C. jejuni lipooligosaccharide (LOS) constituting a major pathogenicity factor responsible for the immunopathological host responses during campylobacteriosis. In this chapter, we summarize the recent progress that has been made in overcoming these fundamental obstacles in Campylobacter research in mice. Modification of the murine host-specific gut microbiota composition and sensitization of the mice to C. jejuni LOS by deletion of genes encoding interleukin-10 or a single IL-1 receptor-related molecule as well as by dietary zinc depletion have yielded reliable murine infection models resembling key features of human campylobacteriosis. These substantial improvements pave the way for a better understanding of the molecular mechanisms underlying pathogen-host interactions. The ongoing validation and standardization of these novel murine infection models will provide the basis for the development of innovative treatment and prevention strategies to combat human campylobacteriosis and collateral damages of C. jejuni infections.
Keywords: Campylobacteriosis models; Colonization resistance; IL-10-deficient mice; Lipooligosaccharide; Toll-like receptor 4.
Similar articles
-
Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis.Microorganisms. 2020 Mar 28;8(4):482. doi: 10.3390/microorganisms8040482. Microorganisms. 2020. PMID: 32231139 Free PMC article. Review.
-
Murine infection models for the investigation of Campylobacter jejuni--host interactions and pathogenicity.Berl Munch Tierarztl Wochenschr. 2015 Mar-Apr;128(3-4):98-103. Berl Munch Tierarztl Wochenschr. 2015. PMID: 25876268
-
Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice.PLoS One. 2012;7(5):e35988. doi: 10.1371/journal.pone.0035988. Epub 2012 May 1. PLoS One. 2012. PMID: 22563475 Free PMC article.
-
Novel murine infection models provide deep insights into the "ménage à trois" of Campylobacter jejuni, microbiota and host innate immunity.PLoS One. 2011;6(6):e20953. doi: 10.1371/journal.pone.0020953. Epub 2011 Jun 15. PLoS One. 2011. PMID: 21698299 Free PMC article.
-
Human Campylobacteriosis-A Serious Infectious Threat in a One Health Perspective.Curr Top Microbiol Immunol. 2021;431:1-23. doi: 10.1007/978-3-030-65481-8_1. Curr Top Microbiol Immunol. 2021. PMID: 33620646 Review.
Cited by
-
Therapeutic effects of oral benzoic acid application during acute murine campylobacteriosis.Eur J Microbiol Immunol (Bp). 2024 May 27;14(3):243-260. doi: 10.1556/1886.2024.00059. Print 2024 Sep 11. Eur J Microbiol Immunol (Bp). 2024. PMID: 38801662 Free PMC article.
-
Garlic Essential Oil as Promising Option for the Treatment of Acute Campylobacteriosis-Results from a Preclinical Placebo-Controlled Intervention Study.Microorganisms. 2021 May 25;9(6):1140. doi: 10.3390/microorganisms9061140. Microorganisms. 2021. PMID: 34070612 Free PMC article.
-
Collider Bias Assessment in Colombian Indigenous Wiwa and Kogui Populations with Chronic Gastroenteric Disorder of Likely Infectious Etiology Suggests Complex Microbial Interactions Rather Than Clear Assignments of Etiological Relevance.Microorganisms. 2024 May 11;12(5):970. doi: 10.3390/microorganisms12050970. Microorganisms. 2024. PMID: 38792799 Free PMC article.
-
Therapeutic and protective approaches to combat Campylobacter jejuni infections.Front Pharmacol. 2025 May 6;16:1572616. doi: 10.3389/fphar.2025.1572616. eCollection 2025. Front Pharmacol. 2025. PMID: 40395728 Free PMC article. Review.
-
Oral curcumin ameliorates acute murine campylobacteriosis.Front Immunol. 2024 May 24;15:1363457. doi: 10.3389/fimmu.2024.1363457. eCollection 2024. Front Immunol. 2024. PMID: 38855111 Free PMC article.
References
-
- Adler HE, DaMassa AJ (1979) Toxicity of endotoxin to chicks. Avian Dis 23(1):174–178 - DOI
-
- Alter T, Bereswill S, Glünder G, Haag L-M, Hänel I, Heimesaat M, Lugert R, Rautenschlein S, Weber R, Zautner A (2011) Die Campylobacteriose des Menschen. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 54(6):728–734. https://doi.org/10.1007/s00103-011-1289-y
-
- Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K, Kim S, Fritz JV, Wilmes P, Ueha S, Matsushima K, Ohno H, Olle B, Sakaguchi S, Taniguchi T, Morita H, Hattori M, Honda K (2013) Treg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature 500(7461):232–236. https://doi.org/10.1038/nature12331 - DOI - PubMed
-
- Auerbach S (1965) Zinc content of plasma, blood, and erythrocytes in normal subjects and in patients with hodgkin’s disease and various hematologic disorders. J Lab Clin Med 65:628–637 - PubMed
-
- Babakhani FK, Bradley GA, Joens LA (1993) Newborn piglet model for campylobacteriosis. Infect Immun 61(8):3466–3475. https://doi.org/10.1128/IAI.61.8.3466-3475.1993 - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical